Skip to content


Newly diagnosed? Visit the Epilepsy Health Center, check out community tips and review resources.
phylisfeinerjohnson posted:
MORRISTOWN, N.J., Sept. 13, 2011 /PRNewswire/ Watson Laboratories, Inc. has confirmed today that it has launched Levetiracetam Extended-Release 500 mg and 750 mg tablets — the generic version of Keppra XR® — following approval of the Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).

Watson has begun shipping the product today. Keppra XR® is indicated to treat partial onset seizures in people 16 years of age and older with epilepsy.

For further information, click on:

Phylis Feiner Johnson
Was this Helpful?
3 of 3 found this helpful

Helpful Tips

Want to change font size?
It is easy to make the font bigger press and hold your control key and click on the + key until it's as big as you like, To make ... More
Was this Helpful?
27 of 41 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

For more information, visit the Duke Health Epilepsy Center